Table 1.
CD1 isoform | Groove volume | TCR | TCR variability: T cell subset designation | Antigens recognized | References |
---|---|---|---|---|---|
CD1a | 1.35 nm3 | αβ | diverse | sulfatide, PE, PI, PC, lyso-PC, fatty acids, squalene, wax esters, dideoxymycobactin | [27, 28, 30, 107] |
CD1b | 2.20 nm3 | αβ | diverse | sulfatide, mycolic acid, glycerol monomycolate, diacylated sulphoglycolipids | [107–110] |
αβ | semi-invariant: GEM T | glucose monomycolate | [35] | ||
αβ | biased: LDN5-like T | glucose monomycolate | [36] | ||
CD1c | 1.78 nm3 | αβ | diverse | phosphomycoketide, mannosyl-phosphomycoketide, lipopeptides | [41, 111] |
γδ | diverse | sulfatide, lyso-PC, phosphomycoketide, mannosyl-phosphomycoketide | [43, 107] | ||
CD1d | 1.65 nm3 | Type I NKT or iNKT cells: | |||
αβ | semi-invariant: Vα14 (mouse) or Vα24 (human) NKT | α-GalCer, β-GalCer, α-GlcCer, α-GalACer, α-GalDAG, α-GlcDAG, cholesteryl α-glucoside, asperamide B, GD3, iGb3, PE, PI, PC, lyso-PC, lysopeptidophosphoglycan | [50–59, 74, 77, 78, 112–116] | ||
αβ | semi-invariant: Vα10 NKT | α-GalCer, α-GlcCer, α-GlcADAG | [81] | ||
Type II NKT, dNKT or vNKT cells: | |||||
αβ | biased: sulfatide-reactive dNKT | sulfatide, β-GlcCer, β-GalCer | [62, 107, 117] | ||
αβ | diverse: “atypical” dNKT | α-GalCer | [97] | ||
αβ | diverse: non-sulfatide-reactive dNKT | PG, PI, cardiolipin, lyso-PE non-lipid small molecules (e.g., PPBF), peptides (synthetic, ovalbumin-derived, collagen-derived) | [60, 61, 63, 98, 99, 102] | ||
TCRγδ+ NKT cells: | |||||
γδ | biased | cardiolipin | [118] | ||
CD1e | 2.00 nm3 | - | - | sulfatide, PI, dimannosylated PI, diacylated sulphoglycolipids, hemi-bis(monoacylglycero)-phosphate | [105, 106] |
Abbreviations: dNKT, diverse NKT; GalCer, galactosylceramide; GalACer, galacturonosylceramide; GalADAG, galacturonosyldiacylglycerol; GalDAG, galactosyldiacylglycerol; GD3, ganglioside D3; GEM, germline-encoded mycolyl-specific; GlcCer, glucosylceramide; iGb3, isoglobotrihexosylceramide; iNKT, invariant NKT; NKT, natural killer T; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; vNKT, variant NKT; PPBF, phenyl 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonate.